Osteotec announces new rebrand and website

As we prepare to celebrate Osteotec’s 30th anniversary we’re pleased to launch our new website, logo and brand refresh, which reflects our growth and evolution over the last three decades.

At the core of our refresh we wanted to deliver  clarity and consistency through our visual messaging that aligned with our core purpose – our dedication to providing patients with the best solutions that improve clinical outcomes.

Our new brand identity pays homage to Osteotec’s history as the UK’s first specialist small joints distributor while also better representing our vision of delivering unparalleled expertise, outstanding service and tailored solutions for our global manufacturing partners and clinicians.

The updated brand has undergone a style transformation that includes a new logo, colour palette, typeface and iconography.

We deconstructed our old logo and created a clean, customised wordmark that reflects our professional expertise and experience. We’re also excited to share our 30th anniversary logo, which will be used throughout our marketing in 2023 to commemorate our three decades of superior services to healthcare professionals.

“Our partners have long known the value we bring to our collaborations, and our brand represents the trust and professionalism they rely on,” said Anthony McClellan, Osteotec Group General Manager.

“Our new brand is a representation of the proven value and confidence we provide them and the wider medical community. As we look to the future, our new brand will go before us into the marketplace as a symbol of the principles and standards we stand for, and the trust our clients put in our services.”

The new Osteotec website has a bold, modern look and feel combining easy navigation and mobile-first design, while also celebrating the company’s history. The new brand will be reflected across the company’s marketing materials and social media platforms.

The refresh comes at an exciting time for Osteotec, having announced our exclusive distribution partnership with Enovis UK & Ireland and Mathys International in November.

Further recent announcements have included UK distribution partnerships with G21, Beznoska and Exabone, aligning with our ambition to provide clinicians with comprehensive solutions that improve patient outcomes.